Clinical Trial Update: Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

A Phase 1 immuno-PET study of the radiolabeled tracer 89Zr-S095012 in patients with advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• 89Zr-S095012

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Advanced Solid Tumor | Phase 1 | Status: TERMINATED